Page last updated: 2024-10-31

midazolam and Drug Withdrawal Symptoms

midazolam has been researched along with Drug Withdrawal Symptoms in 86 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research Excerpts

ExcerptRelevanceReference
"Benzodiazepine withdrawal-induced catatonia is a rare phenomenon in the adult population and has never been reported in a pediatric patient."5.46Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient. ( Duncan-Azadi, CR; Gormley, A; Johnson, PN, 2017)
"Acute and chronic morphine dependence and naloxone-precipitated withdrawal models were employed in the present study."3.71Pretreatment with midazolam suppresses morphine withdrawal response in mice and rats. ( Cao, JL; Ding, HL; Duan, SM; Zeng, YM; Zhang, LC, 2002)
"Fentanyl and midazolam were adjusted to achieve a defined level of analgesia and sedation according to Hartwig score."2.79Continuous infusion of clonidine in ventilated newborns and infants: a randomized controlled trial. ( Balling, G; Behr, J; Blickheuser, R; Dohna-Schwake, C; Gebauer, C; Hahn, M; Harnischmacher, U; Hentschel, R; Hering, F; Hoehn, T; Hünseler, C; Huth, RG; Lieser, U; Möller, O; Müller, A; Müller, C; Röhlig, C; Roth, B; Schubert, S; Trieschmann, U; Wassmer, G, 2014)
"The methadone was then decreased to once daily and tapered off over the next 10 days."2.76A trial of methadone tapering schedules in pediatric intensive care unit patients exposed to prolonged sedative infusions. ( Bowens, CD; Breitzka, RL; Sheeran, PW; Thompson, DG; Thompson, JA; Thompson, MT, 2011)
"Naloxone has been hypothesized to limit opioid tolerance by decreasing adenylate cyclase/cyclic adenosine monophosphate activation."2.73Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children. ( Darnell, CM; Roy, L; Sheeran, P; Stromberg, D; Thompson, J, 2008)
" There was no dose-response effect for effectiveness with either initial or continued drug administration."2.65Midazolam: dose-response studies of effectiveness and rebound insomnia. ( Bixler, EO; Goff, PJ; Kales, A; Soldatos, CR; Vela-Bueno, A, 1983)
"Midazolam was used in 95 patients (56%), with an average dose of 35 (±14) μg/kg/h."1.51Postsurgery analgesic and sedative drug use in a French neonatal intensive care unit: A single-center retrospective cohort study. ( Benahmed-Canat, A; Canat, G; Claris, O; Kassai, B; Nguyen, KA; Paret, N; Plaisant, F; Rabilloud, M; Riche, B, 2019)
"Treatment with carisoprodol and phenobarbital provided additional benefit and can be considered in cases of severe carisoprodol withdrawal."1.46Severe Carisoprodol Withdrawal After a 14-Year Addiction and Acute Overdose. ( Benowitz, NL; Horng, H; Smollin, CG; Vo, KT, 2017)
"Benzodiazepine withdrawal-induced catatonia is a rare phenomenon in the adult population and has never been reported in a pediatric patient."1.46Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient. ( Duncan-Azadi, CR; Gormley, A; Johnson, PN, 2017)
"Our aim was to describe the effect of dosing and genetic factors on sufentanil- and midazolam-induced analgosedation and withdrawal syndrome (WS) in pediatric population."1.43Sufentanil and midazolam dosing and pharmacogenetic factors in pediatric analgosedation and withdrawal syndrome. ( Hronová, K; Pokorná, P; Posch, L; Slanař, O, 2016)
"Because of acute renal failure resulting from rhabdomyolysis hemodialysis was necessary three times."1.35["Liquid ecstasy": gamma-butyrolactone withdrawal delirium with rhabdomyolysis and dialysis dependent renal failure]. ( Busch, HJ; Schwab, T; Supady, A, 2009)
"Withdrawal symptoms were still present 24 h after detoxification and 80% of the patients relapsed during a 6-month follow-up."1.30Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results. ( Bertschy, G; Cucchia, AT; Ferrero, F; Monnat, M; Spagnoli, J, 1998)
"To record the number of children with withdrawal symptoms after the administration of sedatives for mechanical ventilation, and to discuss the possible connection with the administration of midazolam."1.30Occurrence of withdrawal in critically ill sedated children. ( Carl, P; Fonsmark, L; Rasmussen, YH, 1999)
"The fentanyl infusion was decreased by 1 microg/kg/hr every 12-24 hrs and the midazolam infusion was decreased by 0."1.30Subcutaneous administration of fentanyl and midazolam to prevent withdrawal after prolonged sedation in children. ( Tobias, JD, 1999)
"Alcohol use among head and neck cancer patients is common."1.29Trends in the management of alcohol withdrawal syndrome. ( Moore, M; Newman, JP; Terris, DJ, 1995)
" The overall incidence of adverse effects to midazolam in the patients studied was 17%."1.29A prospective study of the adverse effects of midazolam on withdrawal in critically ill children. ( Billingham, I; Choonara, I; Gill, A; Hughes, J; Leach, HJ; Nunn, AJ; Ratcliffe, J; Thornington, R, 1994)
" The switch to oral agents must take into consideration the differences in potency, half-life, and oral bioavailability between the agents."1.29Outpatient therapy of iatrogenic drug dependency following prolonged sedation in the pediatric intensive care unit. ( Deshpande, JK; Gregory, DF; Tobias, JD, 1994)
"When midazolam was readministered, all symptoms disappeared."1.29Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam. ( Booy, LH; Gimbrere, JS; van Engelen, BG, 1993)
" Using a cumulative dosing procedure, PTZ substituted for PTZ, and MDZ, chlordiazepoxide and diazepam (DZP) substituted for MDZ, in a dose-dependent manner."1.28Tolerance, cross-tolerance and withdrawal in rats made dependent on diazepam. ( Boone, MS; Emmett-Oglesby, MW; Pugh, SL, 1992)
" Our laboratory has demonstrated previously that physical dependence to the long-acting chlordiazepoxide in the rat is inducible by a single intoxicating dose, whereas maximal dependence required chronically equivalent maximally tolerable dosing b."1.28Tolerance and physical dependence to a short-acting benzodiazepine, midazolam. ( Boisse, NR; Guarino, JJ; Quaglietta, N; Samoriski, GM, 1990)
"This flumazenil treatment produced a slight attenuation in the degree of tolerance to midazolam on day 6, suggesting that receptor sensitivity to the benzodiazepine agonist may have partially reset."1.28Behavioral differentiation of benzodiazepine ligands after repeated administration in baboons. ( Cook, JM; Griffiths, RR; Sannerud, CA, 1989)
"Midazolam was initiated in an effort to resolve his agitation and the patient continued to receive frequent bolus injections, averaging 22 mg/d over 21 days."1.28Precipitation of benzodiazepine withdrawal following sudden discontinuation of midazolam. ( Finley, PR; Nolan, PE, 1989)
" In naive animals, after the chronic administration of midazolam at 0."1.27[Drug dependence tests on a new anesthesia inducer, midazolam]. ( Hakkei, M; Kubota, A; Kuwahara, A; Nakamura, K, 1986)

Research

Studies (86)

TimeframeStudies, this research(%)All Research%
pre-19909 (10.47)18.7374
1990's32 (37.21)18.2507
2000's21 (24.42)29.6817
2010's20 (23.26)24.3611
2020's4 (4.65)2.80

Authors

AuthorsStudies
Duke, AN1
Tiruveedhula, VVNPB1
Sharmin, D1
Knutson, DE1
Cook, JM3
Platt, DM1
Rowlett, JK1
Dokken, M1
Rustøen, T1
Diep, LM1
Fagermoen, FE1
Huse, RI1
Egerod, I1
Bentsen, GK1
Asada, R1
Hori, H1
Iida, H1
Kawasaki, H1
Goulooze, SC1
Ista, E4
van Dijk, M3
Hankemeier, T1
Tibboel, D5
Knibbe, CAJ1
Krekels, EHJ1
Teah, MK1
Chan, GK1
Wong, MTF1
Yeap, TB1
Neubert, A1
Baarslag, MA1
Dijk, MV1
Rosmalen, JV1
Standing, JF1
Sheng, Y1
Rascher, W1
Roberts, D1
Winslade, J1
Rawcliffe, L1
Hanning, SM1
Metsvaht, T1
Giannuzzi, V1
Larsson, P1
Pokorná, P2
Simonetti, A1
Warrington, SE1
Collier, HK1
Himebauch, AS1
Wolfe, HA1
Kongkiattikul, L1
Dagenais, M1
Ruo, N1
Fontela, P1
Di Genova, T1
Zavalkoff, S1
Benahmed-Canat, A1
Plaisant, F1
Riche, B1
Rabilloud, M1
Canat, G1
Paret, N1
Claris, O1
Kassai, B1
Nguyen, KA1
Larson, GE1
Arnup, SJ1
Clifford, M1
Evans, J1
Hünseler, C1
Balling, G1
Röhlig, C1
Blickheuser, R1
Trieschmann, U1
Lieser, U1
Dohna-Schwake, C1
Gebauer, C1
Möller, O1
Hering, F1
Hoehn, T1
Schubert, S1
Hentschel, R1
Huth, RG1
Müller, A1
Müller, C1
Wassmer, G1
Hahn, M1
Harnischmacher, U1
Behr, J1
Roth, B1
Crispo, AL1
Daley, MJ1
Pepin, JL1
Harford, PH1
Brown, CV1
Ortiz, V1
Giachero, M1
Espejo, PJ1
Molina, VA1
Martijena, ID1
Stewart, R1
Perez, R1
Musial, B1
Lukens, C1
Adjepong, YA1
Manthous, CA1
Zhang, P1
Austin, E1
Thompson, M1
Lin, S1
Vo, KT1
Horng, H1
Smollin, CG1
Benowitz, NL1
Hronová, K1
Posch, L1
Slanař, O1
Duncan-Azadi, CR1
Johnson, PN1
Gormley, A1
Chandrasekaran, PK1
Gamel, C1
de Hoog, M2
Easley, RB1
Nichols, DG1
Duivenvoorden, HJ1
Supady, A1
Schwab, T1
Busch, HJ1
Gupta, A1
Lee, D1
Su, M1
Hafner, V1
Jäger, M1
Matthée, AK1
Ding, R1
Burhenne, J1
Haefeli, WE1
Mikus, G1
Bowens, CD1
Thompson, JA1
Thompson, MT1
Breitzka, RL1
Thompson, DG1
Sheeran, PW1
Wildschut, E1
da Silva, PS1
Passos, RM1
Waisberg, DR1
Stein, M1
Schomacher, J1
Scharbrodt, W1
Preuss, M1
Oertel, MF1
Fernández-Carrión, F1
Gaboli, M1
González-Celador, R1
Gómez de Quero-Masía, P1
Fernández-de Miguel, S1
Murga-Herrera, V1
Serrano-Ayestarán, O1
Sánchez-Granados, JM1
Payo-Pérez, R1
Cao, JL1
Ding, HL1
Zhang, LC1
Duan, SM1
Zeng, YM1
McMahon, LR3
Jerussi, TP1
France, CP3
Cunliffe, M1
McArthur, L1
Dooley, F1
Takara, I1
Tomiyama, H1
Tokumine, J1
Sugahara, K1
Korak-Leiter, M1
Likar, R1
Oher, M1
Trampitsch, E1
Ziervogel, G1
Levy, JV1
Freye, EC1
Maruyama, S1
Nomura, Y1
Fukushige, T1
Eguchi, T1
Nishi, J1
Yoshinaga, M1
Kawano, Y1
Javors, MA1
Raffa, RB1
Cavallo, F1
Capasso, A1
Epstein, D1
Difazio, M1
Hansen, CR1
Gooch, JL1
Such-Neibar, T1
Weber, MD1
Thammasitboon, S1
Rosen, DA1
Pohl-Schickinger, A1
Lemmer, J1
Hübler, M1
Alexi-Meskishvili, V1
Redlin, M1
Berger, F1
Stiller, B1
Darnell, CM1
Thompson, J1
Stromberg, D1
Roy, L1
Sheeran, P1
Li, JX1
Gerak, LR1
Becker, GL1
Kales, A2
Soldatos, CR2
Bixler, EO2
Goff, PJ1
Vela-Bueno, A1
Krajnik, M1
Zylicz, Z1
Strickland, RA1
Berge, KH1
Hantson, P1
Clemessy, JL1
Baud, FJ1
Newman, JP1
Terris, DJ1
Moore, M1
Hughes, J1
Gill, A1
Leach, HJ1
Nunn, AJ1
Billingham, I2
Ratcliffe, J1
Thornington, R2
Choonara, I1
Tobias, JD2
Deshpande, JK1
Gregory, DF1
Bruder, N1
Lassegue, D1
Pelissier, D1
Graziani, N1
François, G1
Legarda, JJ1
Gossop, M1
van Engelen, BG1
Gimbrere, JS1
Booy, LH1
Lawrence, K1
Evans, EB1
Balster, RL1
Loimer, N3
Hofmann, P1
Chaudhry, H1
Gil-Martín, E1
Colado, I1
Fernández-López, A1
Fernández-Briera, A1
Calvo, P1
Weerts, EM1
Kaminski, BJ1
Griffiths, RR3
Loeb, P1
Adnet, P1
Boittiaux, P1
Forget, AP1
Mille, FX1
Cucchia, AT1
Monnat, M1
Spagnoli, J1
Ferrero, F1
Bertschy, G1
Kesavulu, V1
Costarino, AT1
Fonsmark, L1
Rasmussen, YH1
Carl, P1
Hickey, R1
Wells, L1
Wilson, LB1
DeMaria, PA1
Kane, HL1
Reining, KM1
Streel, E1
Dan, B1
Bredas, P1
Clement, B1
Pelc, I1
Verbanck, P1
Pugh, SL1
Boone, MS1
Emmett-Oglesby, MW1
Vigorito, M1
Lau, CE2
Tang, M2
Falk, JL2
Sannerud, CA2
Allen, M1
Kauffman, RE1
Lenz, K2
Presslich, O2
Schmid, R2
Mets, B1
Horsell, A1
Linton, DM1
McLellan, I1
Douglas, E1
Conway, EE1
Singer, LP1
Boisse, NR1
Quaglietta, N1
Samoriski, GM1
Guarino, JJ1
Böhrer, H1
Bach, A1
Layer, M1
Werning, P1
Yutrzenka, GJ1
Patrick, GA1
Rosenberger, W1
Finley, PR1
Nolan, PE1
Kales, JD1
Jacoby, JA1
Sury, MR1
Russell, GN1
Hopkins, CS1
Vivori, E1
Newman, LM1
Hoffman, WE1
Miletich, DJ1
Albrecht, RF1
Kubota, A1
Kuwahara, A1
Hakkei, M1
Nakamura, K1

Clinical Trials (11)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Double Blind, Randomised, Multicentre, Active Controlled, Parallel-group, Phase III Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of Intravenous Clonidine (Hydrochloride) Compared to Midazolam for Sedation in Children From Birth to Less Th[NCT02509273]Phase 328 participants (Actual)Interventional2016-05-31Terminated (stopped due to lack of recruitment)
Phenobarbital Versus Ativan for Refractory Alcohol Withdrawal Treatment in the Intensive Care Unit[NCT04156464]Phase 4142 participants (Anticipated)Interventional2020-07-06Recruiting
Intranasal Sufentanil for Analgesia of Severe Sickle Cell Vaso-occlusive Pain Crisis in the Pediatric Emergency Department: a Double Blind Randomized Versus Placebo Controlled Trial[NCT06181695]Phase 3182 participants (Anticipated)Interventional2024-05-02Not yet recruiting
Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit[NCT02025855]Phase 446 participants (Anticipated)Interventional2014-01-31Enrolling by invitation
Opioid Withdrawal Symptoms in Critically Ill Patients[NCT03374722]55 participants (Actual)Observational2018-01-01Completed
Protocolized Initiation of Clonidine to Prevent Dexmedetomidine Withdrawal: A Prospective Cohort Study[NCT05575219]Phase 4300 participants (Anticipated)Interventional2022-10-08Recruiting
Efficacy of Clonidine in Reducing Iatrogenic-induced Opioid Dependence in Infants:[NCT01360450]Phase 2/Phase 312 participants (Actual)Interventional2011-07-31Terminated (stopped due to The study was treminated because of low accural)
The Impact of Concomitant Ultra Low Dose Infusion Naloxone and Therapeutic Infusion Opioid on Opioid Requirements in Pediatric ICU Patients[NCT00286052]Phase 3128 participants Interventional2002-12-31Completed
Early Lactate-Directed Therapy on the ICU: A Randomized Controlled Trial[NCT00270673]Phase 3350 participants (Anticipated)Interventional2006-02-28Completed
Assessing Current Analgesia and Sedation Weaning Practices in Adult Critically Ill Patients[NCT04422808]2,437 participants (Actual)Observational2021-06-01Completed
Effect of Clonidine vs. Dexmedetomidine in Addition to Standard Treatment in Agitated Delirium in Intensive Care Patients: Pilot Study.[NCT04758936]Phase 450 participants (Anticipated)Interventional2021-02-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Time to Complete Detoxification

Time to complete detoxification is defined as 48 hrs off all opioids/benzodiazepines and study drug with acceptable withdrawal scores of <9 (on average we expect the infant to be enrolled in the study for 2-4 weeks). The scale used to assess withdrawal was the Modified Finnegan Neonatal Withdrawal Scale, which ranges from 0-41, 0 represents no withdrawal and 41 represent maximum withdrawal. (NCT01360450)
Timeframe: up to 4 weeks

,
Interventiondays (Mean)
total days on narcoticsduration on study drug in days
Control37.214.2
Treatment89.521

Reviews

4 reviews available for midazolam and Drug Withdrawal Symptoms

ArticleYear
Managing sedation withdrawal in children who undergo prolonged PICU admission after discharge to the ward.
    Paediatric anaesthesia, 2004, Volume: 14, Issue:4

    Topics: Analgesics; Child; Chloral Hydrate; Clinical Protocols; Critical Care; Follow-Up Studies; Hospital U

2004
Subcutaneous fentanyl and midazolam: an alternative method of weaning after intravenous sedation in pediatric patients.
    Critical care medicine, 1999, Volume: 27, Issue:10

    Topics: Analgesics, Opioid; Child; Fentanyl; Humans; Hypnotics and Sedatives; Injections, Intravenous; Injec

1999
Anesthesia-assisted rapid opiate detoxification: a new procedure in the postanesthesia care unit.
    Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses, 1999, Volume: 14, Issue:4

    Topics: Adult; Anesthesia, General; Anesthetics, Intravenous; Heroin Dependence; Humans; Male; Midazolam; Na

1999
Rebound insomnia and elimination half-life: assessment of individual subject response.
    Journal of clinical pharmacology, 1985, Volume: 25, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, D

1985

Trials

8 trials available for midazolam and Drug Withdrawal Symptoms

ArticleYear
The CLOSED trial; CLOnidine compared with midazolam for SEDation of paediatric patients in the intensive care unit: study protocol for a multicentre randomised controlled trial.
    BMJ open, 2017, 06-21, Volume: 7, Issue:6

    Topics: Adolescent; Analgesics, Opioid; Child; Child Development; Child, Preschool; Clonidine; Delirium; Hum

2017
Continuous infusion of clonidine in ventilated newborns and infants: a randomized controlled trial.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2014, Volume: 15, Issue:6

    Topics: Age Factors; Analgesics; Analgesics, Opioid; Clonidine; Double-Blind Method; Female; Fentanyl; Human

2014
Effect of simultaneous induction and inhibition of CYP3A by St John's Wort and ritonavir on CYP3A activity.
    Clinical pharmacology and therapeutics, 2010, Volume: 87, Issue:2

    Topics: Administration, Oral; Adult; Area Under Curve; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Ind

2010
A trial of methadone tapering schedules in pediatric intensive care unit patients exposed to prolonged sedative infusions.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2011, Volume: 12, Issue:5

    Topics: Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedul

2011
Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.
    Intensive care medicine, 2005, Volume: 31, Issue:3

    Topics: Adolescent; Adult; Aged; Analgesics, Opioid; beta-Endorphin; Blood Pressure; Conscious Sedation; Cri

2005
Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children.
    Pediatrics, 2008, Volume: 121, Issue:5

    Topics: Adolescent; Analgesics, Opioid; Child; Child, Preschool; Conscious Sedation; Critical Illness; Doubl

2008
Midazolam: dose-response studies of effectiveness and rebound insomnia.
    Pharmacology, 1983, Volume: 26, Issue:3

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Double-Blind Method; Electroe

1983
Rebound insomnia and elimination half-life: assessment of individual subject response.
    Journal of clinical pharmacology, 1985, Volume: 25, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, D

1985

Other Studies

75 other studies available for midazolam and Drug Withdrawal Symptoms

ArticleYear
Tolerance and dependence following chronic alprazolam treatment in rhesus monkeys: Role of GABA
    Drug and alcohol dependence, 2021, 11-01, Volume: 228

    Topics: Alprazolam; Animals; Benzodiazepines; Drug Tolerance; Female; Macaca mulatta; Midazolam; Receptors,

2021
Implementation of an algorithm for tapering analgosedation reduces iatrogenic withdrawal syndrome in pediatric intensive care.
    Acta anaesthesiologica Scandinavica, 2023, Volume: 67, Issue:9

    Topics: Adolescent; Algorithms; Analgesics, Opioid; Child; Child, Preschool; Critical Care; Humans; Hypnotic

2023
Benzodiazepine withdrawal catatonia after discontinuing midazolam in young patient with intellectual developmental disorder: A case report.
    Asian journal of psychiatry, 2023, Volume: 89

    Topics: Adult; Benzodiazepines; Catatonia; Developmental Disabilities; Humans; Intellectual Disability; Male

2023
Supervised Multidimensional Item Response Theory Modeling of Pediatric Iatrogenic Withdrawal Symptoms.
    CPT: pharmacometrics & systems pharmacology, 2019, Volume: 8, Issue:12

    Topics: Child; Child, Preschool; Drug Therapy, Combination; Female; Fentanyl; Humans; Iatrogenic Disease; In

2019
Treatment of benzodiazepine withdrawal syndrome in a severe traumatic brain injury patient.
    BMJ case reports, 2021, Jan-08, Volume: 14, Issue:1

    Topics: Adolescent; Brain Injuries, Traumatic; Humans; Hypnotics and Sedatives; Male; Midazolam; Substance W

2021
Evaluation of IV to Enteral Benzodiazepine Conversion Calculations in a Pediatric Intensive Care Setting.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2018, Volume: 19, Issue:11

    Topics: Airway Extubation; Child, Preschool; Diazepam; Drug Dosage Calculations; Drug Substitution; Female;

2018
The impact of a quality improvement project to standardize pain, agitation, and withdrawal assessments on the use of morphine and midazolam in the Pediatric Intensive Care Unit.
    Paediatric anaesthesia, 2019, Volume: 29, Issue:4

    Topics: Analgesics, Opioid; Compliance; Conscious Sedation; Critical Care; Dexmedetomidine; Humans; Hypnotic

2019
Postsurgery analgesic and sedative drug use in a French neonatal intensive care unit: A single-center retrospective cohort study.
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2019, Volume: 26, Issue:3

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Cohort Studies; Drug Utilization; Femal

2019
How does the introduction of a pain and sedation management guideline in the paediatric intensive care impact on clinical practice? A comparison of audits pre and post guideline introduction.
    Australian critical care : official journal of the Confederation of Australian Critical Care Nurses, 2013, Volume: 26, Issue:3

    Topics: Analgesics; Clonidine; Documentation; Guideline Adherence; Humans; Intensive Care Units, Pediatric;

2013
Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Pharmacotherapy, 2014, Volume: 34, Issue:9

    Topics: Adult; Aged; Benzodiazepines; Cohort Studies; Dexmedetomidine; Ethanol; Female; Humans; Hypnotics an

2014
The effect of Midazolam and Propranolol on fear memory reconsolidation in ethanol-withdrawn rats: influence of d-cycloserine.
    The international journal of neuropsychopharmacology, 2015, Jan-23, Volume: 18, Issue:4

    Topics: Amygdala; Animals; Anti-Anxiety Agents; Central Nervous System Depressants; Conditioning, Psychologi

2015
Outcomes of Patients with Alcohol Withdrawal Syndrome Treated with High-Dose Sedatives and Deferred Intubation.
    Annals of the American Thoracic Society, 2016, Volume: 13, Issue:2

    Topics: Adult; Alcohol Withdrawal Seizures; APACHE; Central Nervous System Depressants; Cohort Studies; Crit

2016
Challenges in a large mixed drug overdose patient.
    BMJ case reports, 2016, Jun-22, Volume: 2016

    Topics: Adult; Anticonvulsants; Body Temperature Regulation; Critical Care; Delirium; Diazepam; Drug Overdos

2016
Severe Carisoprodol Withdrawal After a 14-Year Addiction and Acute Overdose.
    The Journal of emergency medicine, 2017, Volume: 52, Issue:5

    Topics: Adult; Carisoprodol; Dexmedetomidine; Drug Overdose; Fentanyl; Haloperidol; Humans; Hypnotics and Se

2017
Sufentanil and midazolam dosing and pharmacogenetic factors in pediatric analgosedation and withdrawal syndrome.
    Physiological research, 2016, 12-21, Volume: 65, Issue:Suppl 4

    Topics: Adjuvants, Anesthesia; Child; Dose-Response Relationship, Drug; Female; Genetic Variation; Humans; I

2016
Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient.
    A & A case reports, 2017, May-01, Volume: 8, Issue:9

    Topics: Catatonia; Child; Drug Administration Schedule; Humans; Hypnotics and Sedatives; Infusions, Intraven

2017
Employing mirtazapine to aid benzodiazepine withdrawal.
    Singapore medical journal, 2008, Volume: 49, Issue:6

    Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Humans; Male; Mianserin; Midazolam; Mi

2008
Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: a first evaluation.
    Critical care medicine, 2008, Volume: 36, Issue:8

    Topics: Adolescent; Analgesics, Opioid; Child; Child, Hospitalized; Child, Preschool; Female; Humans; Hypnot

2008
Withdrawal assessment in the pediatric intensive care unit: quantifying a morbidity of pain and sedation management in the critically ill child.
    Critical care medicine, 2008, Volume: 36, Issue:8

    Topics: Analgesics, Opioid; Anesthetics, Intravenous; Humans; Infant; Intensive Care Units, Pediatric; Midaz

2008
Construction of the Sophia Observation withdrawal Symptoms-scale (SOS) for critically ill children.
    Intensive care medicine, 2009, Volume: 35, Issue:6

    Topics: Adolescent; Analgesics, Opioid; Child; Child, Hospitalized; Critical Illness; Female; Humans; Hypnot

2009
["Liquid ecstasy": gamma-butyrolactone withdrawal delirium with rhabdomyolysis and dialysis dependent renal failure].
    Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:18

    Topics: 4-Butyrolactone; Acute Kidney Injury; Adrenergic alpha-Agonists; Benzodiazepines; Clonidine; GABA Mo

2009
Comparing dexmedetomidine with midazolam for sedation of patients in the ICU.
    JAMA, 2009, Jun-17, Volume: 301, Issue:23

    Topics: Adrenergic alpha-Agonists; Conscious Sedation; Critical Care; Dexmedetomidine; GABA Modulators; Huma

2009
Creating or preventing opioid addiction, finding the right dose.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2011, Volume: 12, Issue:5

    Topics: Female; Fentanyl; Humans; Hypnotics and Sedatives; Intensive Care Units, Pediatric; Male; Methadone;

2011
Withdrawal treatment with clonidine after prolonged use of chloral hydrate in a pediatric intensive care patient.
    Paediatric anaesthesia, 2011, Volume: 21, Issue:10

    Topics: Adrenergic alpha-Agonists; Analgesics, Opioid; Chloral Hydrate; Clonidine; Fentanyl; Humans; Hypnoti

2011
Cerebrospinal fluid lactate concentration after withdrawal of metabolic suppressive therapy in subarachnoid hemorrhage.
    Acta neurochirurgica. Supplement, 2012, Volume: 114

    Topics: Adult; Aged; Female; Fentanyl; Glasgow Outcome Scale; Humans; Hypnotics and Sedatives; Intensive Car

2012
Withdrawal syndrome in the pediatric intensive care unit. Incidence and risk factors.
    Medicina intensiva, 2013, Volume: 37, Issue:2

    Topics: Adolescent; Analgesics, Opioid; Child; Child, Preschool; Cohort Studies; Female; Fentanyl; Humans; H

2013
Pretreatment with midazolam suppresses morphine withdrawal response in mice and rats.
    Acta pharmacologica Sinica, 2002, Volume: 23, Issue:8

    Topics: Adenosine Monophosphate; Animals; Anti-Anxiety Agents; Mice; Midazolam; Morphine Dependence; Naloxon

2002
Stereoselective discriminative stimulus effects of zopiclone in rhesus monkeys.
    Psychopharmacology, 2003, Volume: 165, Issue:3

    Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Azabicyclo Compounds; Diazepam; Discrimination L

2003
[Withdrawal syndrome in a critically ill child after sedation with midazolam and fentanyl].
    Masui. The Japanese journal of anesthesiology, 2004, Volume: 53, Issue:7

    Topics: Child; Critical Illness; Esophageal Stenosis; Esophagoplasty; Female; Fentanyl; Humans; Hypnotics an

2004
Suspected takotsubo cardiomyopathy caused by withdrawal of bupirenorphine in a child.
    Circulation journal : official journal of the Japanese Circulation Society, 2006, Volume: 70, Issue:4

    Topics: Age Factors; Analgesics, Opioid; Buprenorphine; Cardiomyopathies; Child, Preschool; Echocardiography

2006
Changes in relative potency among positive GABA(A) receptor modulators upon discontinuation of chronic benzodiazepine treatment in rhesus monkeys.
    Psychopharmacology, 2007, Volume: 192, Issue:1

    Topics: Animals; Behavior, Animal; Benzodiazepines; Diazepam; Discrimination Learning; Dose-Response Relatio

2007
Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists.
    European journal of pharmacology, 2007, Jun-14, Volume: 564, Issue:1-3

    Topics: Analysis of Variance; Animals; Benzodiazepines; Clorazepate Dipotassium; Dose-Response Relationship,

2007
Orofacial automatisms induced by acute withdrawal from high-dose midazolam mimicking nonconvulsive status epilepticus in a child.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Apr-15, Volume: 22, Issue:5

    Topics: Analgesics, Opioid; Child, Preschool; Critical Care; Dose-Response Relationship, Drug; Drug Administ

2007
Prolonged, severe intrathecal baclofen withdrawal syndrome: a case report.
    Archives of physical medicine and rehabilitation, 2007, Volume: 88, Issue:11

    Topics: Adolescent; Baclofen; Cerebral Palsy; Child; Critical Care; Cross Infection; Device Removal; Dose-Re

2007
Acute discontinuation syndrome from dexmedetomidine after protracted use in a pediatric patient.
    Paediatric anaesthesia, 2008, Volume: 18, Issue:1

    Topics: Analgesia, Epidural; Blood Pressure; Cardiac Catheterization; Cardiovascular Diseases; Child, Presch

2008
Intravenous clonidine infusion in infants after cardiovascular surgery.
    Paediatric anaesthesia, 2008, Volume: 18, Issue:3

    Topics: Analgesia; Analgesics; Analgesics, Opioid; Blood Pressure; Body Temperature; Clonidine; Female; Fent

2008
Interactions between Delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception.
    Psychopharmacology, 2008, Volume: 199, Issue:2

    Topics: Analgesics; Analgesics, Opioid; Animals; Data Interpretation, Statistical; Discrimination, Psycholog

2008
Terminal restlessness and nicotine withdrawal.
    Lancet (London, England), 1995, Oct-14, Volume: 346, Issue:8981

    Topics: Aged; Akathisia, Drug-Induced; Humans; Hypnotics and Sedatives; Male; Midazolam; Nicotine; Substance

1995
Management of alcohol withdrawal.
    Mayo Clinic proceedings, 1995, Volume: 70, Issue:12

    Topics: Adrenergic alpha-Agonists; Alcoholism; Anti-Anxiety Agents; Clonidine; Diazepam; Humans; Midazolam;

1995
Withdrawal syndrome following midazolam infusion.
    Intensive care medicine, 1995, Volume: 21, Issue:2

    Topics: Adult; Amitriptyline; Drug Overdose; Female; Humans; Midazolam; Seizures; Substance Withdrawal Syndr

1995
Trends in the management of alcohol withdrawal syndrome.
    The Laryngoscope, 1995, Volume: 105, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Alcohol Withdrawal Delirium; Anti-Anxiety Agents; Chlordiazepoxide;

1995
A prospective study of the adverse effects of midazolam on withdrawal in critically ill children.
    Acta paediatrica (Oslo, Norway : 1992), 1994, Volume: 83, Issue:11

    Topics: Child; Child Behavior; Child, Preschool; Critical Illness; Hallucinations; Humans; Incidence; Infant

1994
Outpatient therapy of iatrogenic drug dependency following prolonged sedation in the pediatric intensive care unit.
    Intensive care medicine, 1994, Volume: 20, Issue:7

    Topics: Child; Female; Fentanyl; Humans; Iatrogenic Disease; Infant; Lorazepam; Male; Methadone; Midazolam;

1994
Energy expenditure and withdrawal of sedation in severe head-injured patients.
    Critical care medicine, 1994, Volume: 22, Issue:7

    Topics: Acute Disease; Adult; Blood Pressure; Craniocerebral Trauma; Energy Metabolism; Fentanyl; Glasgow Co

1994
A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation.
    Drug and alcohol dependence, 1994, Volume: 35, Issue:2

    Topics: Administration, Oral; Adult; Conscious Sedation; Drug Administration Schedule; Follow-Up Studies; Gu

1994
Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam.
    The Annals of pharmacotherapy, 1993, Volume: 27, Issue:5

    Topics: Aerophagy; Conscious Sedation; Fever; Humans; Infant; Infant, Newborn; Male; Midazolam; Substance Wi

1993
Reversal of midazolam sedation.
    Critical care medicine, 1993, Volume: 21, Issue:9

    Topics: Akathisia, Drug-Induced; Conscious Sedation; Critical Care; Flumazenil; Humans; Midazolam; Substance

1993
Inhaled 1,1,1-trichloroethane-produced physical dependence in mice: effects of drugs and vapors on withdrawal.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 264, Issue:2

    Topics: Administration, Inhalation; Animals; Chlorpromazine; Ethanol; Male; Mice; Midazolam; Pentobarbital;

1993
Ultrashort noninvasive opiate detoxification.
    The American journal of psychiatry, 1993, Volume: 150, Issue:5

    Topics: Adult; Heroin Dependence; Humans; Male; Midazolam; Naloxone; Naltrexone; Ondansetron; Substance With

1993
Effects of chronic treatment with ethanol and withdrawal on levels of monoamines in rat cerebral cortex and striatum. Influence of midazolam, thiopenthal and somatostatin.
    The international journal of biochemistry & cell biology, 1995, Volume: 27, Issue:12

    Topics: Animals; Anti-Anxiety Agents; Biogenic Monoamines; Cerebral Cortex; Corpus Striatum; Ethanol; Hydrox

1995
Stable low-rate midazolam self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons.
    Psychopharmacology, 1998, Volume: 135, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Feeding Behavior; Flumazenil; Male; Midazolam; Papio; Self Administrat

1998
[Benzodiazepine withdrawal presenting as pseudo-surgical abdominal pain].
    Annales francaises d'anesthesie et de reanimation, 1997, Volume: 16, Issue:5

    Topics: Abdomen, Acute; Adult; Alprazolam; Anti-Anxiety Agents; Bromazepam; Diagnosis, Differential; Headach

1997
Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results.
    Drug and alcohol dependence, 1998, Nov-01, Volume: 52, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Anesthesia, General; Clonidine; Drug Therapy, Combination;

1998
Pediatric sedation withdrawal: recognizing the need for refinement in a necessary therapy.
    Critical care medicine, 1999, Volume: 27, Issue:1

    Topics: Adolescent; Analgesics, Opioid; Child; Child, Preschool; Critical Care; Dose-Response Relationship,

1999
Occurrence of withdrawal in critically ill sedated children.
    Critical care medicine, 1999, Volume: 27, Issue:1

    Topics: Adolescent; Analgesics, Opioid; Child; Child, Preschool; Critical Care; Dose-Response Relationship,

1999
Subcutaneous administration of fentanyl and midazolam to prevent withdrawal after prolonged sedation in children.
    Critical care medicine, 1999, Volume: 27, Issue:10

    Topics: Analgesics, Opioid; Body Weight; Child; Child, Preschool; Conscious Sedation; Fentanyl; Humans; Hypn

1999
Interference with withdrawal signs of naloxone-induced opiate withdrawal under anesthesia is anesthetic-specific in opiate-dependent rats.
    Life sciences, 2001, Dec-21, Volume: 70, Issue:5

    Topics: Anesthesia, General; Anesthetics, Dissociative; Animals; Defecation; Dose-Response Relationship, Dru

2001
Tolerance, cross-tolerance and withdrawal in rats made dependent on diazepam.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:2

    Topics: Animals; Chlordiazepoxide; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Drug

1992
Midazolam withdrawal and discriminative motor control: effects of FG 7142 and Ro 15-1788.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 39, Issue:2

    Topics: Animals; Brain Chemistry; Carbolines; Discrimination, Psychological; Dose-Response Relationship, Dru

1991
Behavioral effects of benzodiazepine ligands in non-dependent, diazepam-dependent and diazepam-withdrawn baboons.
    European journal of pharmacology, 1991, Sep-17, Volume: 202, Issue:2

    Topics: Animals; Behavior, Animal; Benzodiazepines; Carbolines; Diazepam; Dose-Response Relationship, Drug;

1991
Fentanyl, fads, and folly: who will adopt the therapeutic orphans?
    The Journal of pediatrics, 1991, Volume: 119, Issue:4

    Topics: Drug Tolerance; Fentanyl; Humans; Infant; Infant, Newborn; Midazolam; Substance Withdrawal Syndrome

1991
Rapid transition from methadone maintenance to naltrexone.
    Lancet (London, England), 1990, Jan-13, Volume: 335, Issue:8681

    Topics: Flumazenil; Humans; Methadone; Midazolam; Naltrexone; Substance Withdrawal Syndrome

1990
Midazolam-induced benzodiazepine withdrawal syndrome.
    Anaesthesia, 1991, Volume: 46, Issue:1

    Topics: Akathisia, Drug-Induced; Humans; Intermittent Positive-Pressure Ventilation; Male; Midazolam; Middle

1991
Midazolam withdrawal syndrome.
    Anaesthesia, 1991, Volume: 46, Issue:5

    Topics: Conscious Sedation; Humans; Isoflurane; Midazolam; Substance Withdrawal Syndrome

1991
Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates.
    The American journal of psychiatry, 1991, Volume: 148, Issue:7

    Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methadone; Mid

1991
Acute benzodiazepine withdrawal after midazolam in children.
    Critical care medicine, 1990, Volume: 18, Issue:4

    Topics: Acute Disease; Child; Humans; Infant; Midazolam; Substance Withdrawal Syndrome

1990
Tolerance and physical dependence to a short-acting benzodiazepine, midazolam.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 252, Issue:3

    Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tole

1990
Clonidine as a sedative adjunct in intensive care.
    Intensive care medicine, 1990, Volume: 16, Issue:4

    Topics: Clonidine; Critical Care; Drug Synergism; Drug Therapy, Combination; Fentanyl; Gastrectomy; Humans;

1990
Behavioral differentiation of benzodiazepine ligands after repeated administration in baboons.
    European journal of pharmacology, 1989, Aug-29, Volume: 167, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Carbolines; Drug Tolerance; Flumazenil; Injections,

1989
Substitution of temazepam and midazolam in pentobarbital-dependent rats.
    Physiology & behavior, 1989, Volume: 46, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Arousal; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred St

1989
Precipitation of benzodiazepine withdrawal following sudden discontinuation of midazolam.
    DICP : the annals of pharmacotherapy, 1989, Volume: 23, Issue:2

    Topics: Anxiety; Humans; Jejunostomy; Male; Midazolam; Middle Aged; Morphine; Pneumonia; Postoperative Compl

1989
Acute benzodiazepine withdrawal syndrome after midazolam infusions in children.
    Critical care medicine, 1989, Volume: 17, Issue:3

    Topics: Acute Disease; Akathisia, Drug-Induced; Child; Child, Preschool; Cognition Disorders; Confusion; Fem

1989
Regional blood flow and cerebral metabolic changes during alcohol withdrawal and following midazolam therapy.
    Anesthesiology, 1985, Volume: 63, Issue:4

    Topics: Anesthesia, Inhalation; Animals; Benzodiazepines; Blood Gas Analysis; Blood Pressure; Brain; Ethanol

1985
Midazolam and discriminative motor control: chronic administration, withdrawal and modulation by the antagonist Ro 15-1788.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 246, Issue:3

    Topics: Animals; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Flumazenil; Mal

1988
[Drug dependence tests on a new anesthesia inducer, midazolam].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1986, Volume: 88, Issue:2

    Topics: Animals; Injections, Intravenous; Macaca fascicularis; Male; Midazolam; Pentobarbital; Self Administ

1986